CD274 and hepatocellular carcinoma: PD-L1 overexpression was associated with worse overall survival in several human cancers including esophageal cancer, gastric cancer, hepatocellular carcinoma, urothelial cancer, colorectal cancer and oropharyngeal squamous cell carcinoma [10–12].